Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s.

Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s. Abstract Text:

S Veluchamy,C L Saver,

Technology assessment in the 1990s must become an integral part of a hospital's strategic priority goals, with active participation of physicians and top management. Technology assessment should involve a wide range of criteria and health care consumer expectations, so that the appropriateness, effectiveness, cost-effectiveness, and quality improvement aspects of new technologies are all considered. Mount Carmel Health's Advanced Treatment and Bionics Institute (ATBI), established in 1986, monitors significant developments in new technologies and performs technology and outcomes assessments. ATBI activities, which have facilitated adoption of 35 treatment-based projects, are integrated into the existing QA structure of Mount Carmel hospitals. Through resolution of identified problems, quality care can be promoted, while providing patients innovative medical treatments.

Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s. Publishing Authors By Initials

S Veluchamy,CL Saver,

For similar health care economics and organizations: technology assessment, biomedical research abstracts see: health care economics and organizations: technology assessment, biomedical research

PUBMED ID PMID:

MEDLINE DATE:

Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: QRB. Quality review bulletin

VOLUME: 16

Page Numbers: 223-8

Journal Abbreviation:

ISSN: 0097-5990

DAY: 20

MONTH: Jun

YEAR: 1990

Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7504127

Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s. Keywords Mesh Terms:

KEYWORDS: Technology Assessment, Biomedical

MESH TERMS: organization & administration

Chemical & Substance for Abstract: Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s.

AFFILIATION: Advanced Treatment and Bionics Institute (ATBI), Mount Carmel Health, Columbus, OH.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: QRB Qual Rev Bull

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s Related Publications

• 'Just-in-time' business education for family physicians.
• A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions.
• Being prepared for donation after cardiac death.
• Bits and bytes of planning new ORs.
• Clinical technology assessment, cost-effective adoption, and quality management by hospitals in the 1990s.
• Cryptogenic stroke in patients with patent foramen ovale.
• Cultural competency benefits patients, therapists.
• Diagnosis of Lacunar Infarcts within 6 Hours of Onset by Clinical and CT Criteria Versus MRI.
• Emerging risk factors for stroke: Patent foramen ovale, proximal aortic atherosclerosis, antiphospholipid antibodies, and activated protein C resistance.
• Ground rules for vendors in the OR.
• How can an OR be like the Ritz-Carlton?
• Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years.
• Introduction.
• Is out-of-network right for your ASC?
• Knowing when to stop: DNR in the OR.
• Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials.
• OR business conference in San Francisco.
• OR staffing picture worsens, with RN vacancies, open positions up.
• ORs go green for staff, planet benefits.
• Outpatient practice patterns after stroke hospitalization among neurologists.
• Prior antiplatelet use and infarct volume in ischemic stroke.
• Serum calcium as prognosticator in ischemic stroke.
• Substance abuse in the OR: saving lives through treatment, prevention. 2.
• Substance abuse in the OR: why managers should not ignore it.
• Systemic antibiotics and tooth loss in periodontal disease.
• Tips for a successful hire in your ASC.
• Tips for surviving an OR building project.
• Trends in OR design follow calls for safety, evidence-based practice.
• WHO launches global program for safe surgery, with checklist.
• Ways to break loose from OR holds.